{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:09:16Z","timestamp":1791425356059,"version":"4.3.3"},"reference-count":26,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T00:00:00Z","timestamp":1337904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"GOELAMS"},{"name":"DRCI"},{"name":"CHU de Grenoble"},{"name":"French MCL network"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Molecular minimal residual disease (\n                    <jats:styled-content style=\"fixed-case\">MRD<\/jats:styled-content>\n                    ) analysis is fast emerging as an essential clinical decision\u2010making tool for the treatment and follow\u2010up of mature B cell malignancies. Current Euro\n                    <jats:styled-content style=\"fixed-case\">MRD<\/jats:styled-content>\n                    consensus\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">IGH<\/jats:styled-content>\n                    <\/jats:italic>\n                    real\u2010time quantitative polymerase chain reaction\n                    <jats:styled-content style=\"fixed-case\">RQ<\/jats:styled-content>\n                    \u2010\n                    <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\n                    assays rely on flow cytometric assessment of diagnostic tumour burdens to construct \u2018normalized\u2019, patient\u2010specific, diagnostic\n                    <jats:styled-content style=\"fixed-case\">DNA<\/jats:styled-content>\n                    \u2010based\n                    <jats:styled-content style=\"fixed-case\">MRD<\/jats:styled-content>\n                    quantification standards. Here, we propose a new \u2018hybrid\u2019 assay that relies on plasmid\u2010based quantification of patient\u2010specific\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">IGH VDJ<\/jats:styled-content>\n                    <\/jats:italic>\n                    targets by consensus\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">IGH<\/jats:styled-content>\n                    <\/jats:italic>\n                    real time (\n                    <jats:styled-content style=\"fixed-case\">RQ<\/jats:styled-content>\n                    )\u2010\n                    <jats:styled-content style=\"fixed-case\">PCR<\/jats:styled-content>\n                    , combined with Euro\n                    <jats:styled-content style=\"fixed-case\">MRD<\/jats:styled-content>\n                    guidelines, for\n                    <jats:styled-content style=\"fixed-case\">MRD<\/jats:styled-content>\n                    monitoring in lymphoid malignancies. This assay was evaluated for\n                    <jats:styled-content style=\"fixed-case\">MRD<\/jats:styled-content>\n                    assessment in a total of 273 samples from 29 mantle cell lymphoma (\n                    <jats:styled-content style=\"fixed-case\">MCL<\/jats:styled-content>\n                    ) patients treated within a Groupe Ouest Est d'Etude des Leuc\u00e9mies et Autres Maladies du Sang (GOELAMS) Phase\n                    <jats:styled-content style=\"fixed-case\">II<\/jats:styled-content>\n                    trial and was feasible, reliable and consistently comparable to gold\u2010standard\n                    <jats:styled-content style=\"fixed-case\">MRD<\/jats:styled-content>\n                    techniques (99% concordance across all samples including 32 samples within the quantitative range) when analysed in parallel (117 samples). Integrating clinical prognostic parameters and\n                    <jats:styled-content style=\"fixed-case\">MRD<\/jats:styled-content>\n                    status in peripheral blood at the post\u2010induction stage was predictive of progression\u2010free survival (\n                    <jats:italic>P<\/jats:italic>\n                    \u00a0=\u00a00\u00b7034) thus demonstrating the clinical utility of the approach. Plasmid\u2010based standards for the quantification of\n                    <jats:italic>\n                      <jats:styled-content style=\"fixed-case\">IGH VDJ<\/jats:styled-content>\n                    <\/jats:italic>\n                    targets are therefore confirmed to offer new opportunities for further standardization and clinical evaluation of\n                    <jats:styled-content style=\"fixed-case\">MRD<\/jats:styled-content>\n                    \u2010guided management of patients with mature B cell malignancies.\n                  <\/jats:p>","DOI":"10.1111\/j.1365-2141.2012.09161.x","type":"journal-article","created":{"date-parts":[[2012,5,25]],"date-time":"2012-05-25T03:35:30Z","timestamp":1337916930000},"page":"186-197","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cloned\n                    <i>\n                      <scp>IGH VDJ<\/scp>\n                    <\/i>\n                    targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leuc\u00e9mies et Autres Maladies du Sang"],"prefix":"10.1111","volume":"158","author":[{"given":"Estelle","family":"Gimenez","sequence":"first","affiliation":[{"name":"INSERM U823, Institut Albert Bonniot Grenoble France"},{"name":"Universit\u00e9 Joseph Fourier\u2010Grenoble I Institut Albert Bonniot Grenoble France"},{"name":"Plateforme de g\u00e9n\u00e9tique mol\u00e9culaire des cancers, P\u00f4le de Biologie CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Chauvet","sequence":"additional","affiliation":[{"name":"INSERM U823, Institut Albert Bonniot Grenoble France"},{"name":"Universit\u00e9 Joseph Fourier\u2010Grenoble I Institut Albert Bonniot Grenoble France"},{"name":"Plateforme de g\u00e9n\u00e9tique mol\u00e9culaire des cancers, P\u00f4le de Biologie CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Rabin","sequence":"additional","affiliation":[{"name":"Plateforme de g\u00e9n\u00e9tique mol\u00e9culaire des cancers, P\u00f4le de Biologie CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Puteaud","sequence":"additional","affiliation":[{"name":"Plateforme de g\u00e9n\u00e9tique mol\u00e9culaire des cancers, P\u00f4le de Biologie CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Duley","sequence":"additional","affiliation":[{"name":"INSERM U823, Institut Albert Bonniot Grenoble France"},{"name":"Universit\u00e9 Joseph Fourier\u2010Grenoble I Institut Albert Bonniot Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sieme","family":"Hamaidia","sequence":"additional","affiliation":[{"name":"INSERM U823, Institut Albert Bonniot Grenoble France"},{"name":"Universit\u00e9 Joseph Fourier\u2010Grenoble I Institut Albert Bonniot Grenoble France"},{"name":"P\u00f4le recherche CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Bruder","sequence":"additional","affiliation":[{"name":"INSERM U823, Institut Albert Bonniot Grenoble France"},{"name":"Universit\u00e9 Joseph Fourier\u2010Grenoble I Institut Albert Bonniot Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Rolland\u2010Neyret","sequence":"additional","affiliation":[{"name":"P\u00f4le recherche CHU de Grenoble Grenoble France"},{"name":"P\u00f4le de Canc\u00e9rologie et d'H\u00e9matologie CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Le Gouill","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie clinique CHU de Nantes Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[{"name":"H\u00e9matologie H\u00f4tel Dieu CHU de Clermont Ferrand, Boulevard Leon Malfreyt Clermont Ferrand France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Voog","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie Clinique Victor Hugo, 1 rue Victor Hugo Le Mans France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Maisonneuve","sequence":"additional","affiliation":[{"name":"Service d'H\u00e9matologie La Roche sur Yon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"Jacob","sequence":"additional","affiliation":[{"name":"INSERM U823, Institut Albert Bonniot Grenoble France"},{"name":"Universit\u00e9 Joseph Fourier\u2010Grenoble I Institut Albert Bonniot Grenoble France"},{"name":"Laboratoire d'immunologie cellulaire CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Leroux","sequence":"additional","affiliation":[{"name":"INSERM U823, Institut Albert Bonniot Grenoble France"},{"name":"Universit\u00e9 Joseph Fourier\u2010Grenoble I Institut Albert Bonniot Grenoble France"},{"name":"Plateforme de g\u00e9n\u00e9tique mol\u00e9culaire des cancers, P\u00f4le de Biologie CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie C.","family":"B\u00e9n\u00e9","sequence":"additional","affiliation":[{"name":"Immunologie CHU de Nancy &amp; Nancy Universit\u00e9 Vandoeuvre les Nancy France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Formisano\u2010Tr\u00e9ziny","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 de la M\u00e9diterran\u00e9e Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Gabert","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine Universit\u00e9 de la M\u00e9diterran\u00e9e Marseille France"},{"name":"Laboratoire de Biologie Mol\u00e9culaire, H\u00f4pital Nord Marseille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9my","family":"Gressin","sequence":"additional","affiliation":[{"name":"INSERM U823, Institut Albert Bonniot Grenoble France"},{"name":"Universit\u00e9 Joseph Fourier\u2010Grenoble I Institut Albert Bonniot Grenoble France"},{"name":"P\u00f4le de Canc\u00e9rologie et d'H\u00e9matologie CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary B.","family":"Callanan","sequence":"additional","affiliation":[{"name":"INSERM U823, Institut Albert Bonniot Grenoble France"},{"name":"Universit\u00e9 Joseph Fourier\u2010Grenoble I Institut Albert Bonniot Grenoble France"},{"name":"Plateforme de g\u00e9n\u00e9tique mol\u00e9culaire des cancers, P\u00f4le de Biologie CHU de Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,5,25]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3116"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70062-6"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11267"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2009.140"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.1.309"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.496507"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-016725"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403135"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.011759"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1309\/AJCP1GYI7EHQYUYK"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70074-2"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdr450"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.07.007"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.7172"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.050203"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-159624"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-189977"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2845"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-06-230250"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404584"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08228.x"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08315.x"},{"key":"e_1_2_8_24_1","first-page":"145","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow S.H.","year":"2008"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404535"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404586"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.532893"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2012.09161.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2012.09161.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2012.09161.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T03:55:52Z","timestamp":1695614152000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2012.09161.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,25]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1111\/j.1365-2141.2012.09161.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09161.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717297959.792752812","asserted-by":"object"}]},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,25]]},"assertion":[{"value":"2011-10-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-03-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-05-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}